Data / Form D filings / COLUMBIA LABORATORIES INC
COLUMBIA LABORATORIES INC: Form D filing
COLUMBIA LABORATORIES INC, a pharmaceuticals company in Livingston, NJ, filed a Form D with the SEC in 2010. The latest, on July 15, 2010, reports $24.5 million sold of a $24.5 million offering to 25 investors.
Find out what COLUMBIA LABORATORIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 354 EISENHOWER PARKWAY, Livingston, NJ, 07039
- Phone
- (973) 994-3999
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 821995
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2010 | New notice | $24,528,629 | $24,528,629 | $0 | 25 | Jul 2, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Selwyn P. Oskowitz, M.D. | Director | |
| Michael A. McGrane | Executive Officer | |
| Stephen G. Kasnet | Director | |
| Anthony R. Campbell | Director | |
| Lawrence A. Gyenes | Executive Officer | |
| Valerie L. Andrews | Director | |
| James S. Crofton | Director | |
| Frank C. Condella | Executive Officer, Director | |
| Edward A. Blechschmidt | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jul 12, 2010 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what COLUMBIA LABORATORIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.